文献速递骨肌DR

ACR Bone-RADS 在潜在肿瘤性骨病变 X 线评估中的诊断效能与可重复性

Diagnostic performance and reproducibility of ACR Bone-RADS for the radiographic evaluation of potentially neoplastic bone lesions.
PubMed 文献 · Eur J Radiol · 2025-04-21

回顾性纳入 285 例组织学证实的四肢骨病变患者,由两名骨肌放射科医生和一名初级放射科医生按 ACR Bone-RADS 评分。评分可重复性高,鉴别良性与潜在侵袭性病变 AUC=0.82;Bone-RADS≥3 为阈值时敏感度和 NPV 欠佳,排除内生软骨瘤和非典型软骨性肿瘤后 AUC 升至 0.92。

要点

  • ACR Bone-RADS 评分在大多数类别上可重复性达实质至几乎完全一致。
  • 评分鉴别良恶性 AUC=0.82,但以 Bone-RADS≥3 为阈值时敏感度和 NPV 欠佳。
  • 排除内生软骨瘤和非典型软骨性肿瘤后 AUC 提升至 0.92。

核心结论

  • ACR Bone-RADS 评分可重复性高,识别良性病变准确度好;在软骨性肿瘤中评分可能低估病变,提示对 Bone-RADS-2 软骨性病变可考虑追加影像检查而非 X 线随访。

研究设计与样本

  • 回顾性纳入 285 例组织学证实的四肢骨病变患者,X 线摄于活检或手术前三个月内;由两名骨肌放射科医生(Reader 1 和 Reader 2,骨肿瘤影像经验分别为 10 年和 3 年)和一名初级普通放射科医生(Reader 3)按 ACR Bone-RADS 评分系统评估,以组织学为参考标准。

诊断标准与关键数值

  • 以专家放射科医生诊断为基础、组织学为参考标准,计算敏感度、特异度、PPV、NPV;Bone-RADS 评分鉴别良性与潜在侵袭性病变 AUC=0.82,排除内生软骨瘤和非典型软骨性肿瘤后 AUC=0.92;Bone-RADS≥3 为阈值时敏感度和 NPV 欠佳;各评分类别计算百分比一致率、Cohen's Kappa 和 Conger's Kappa,最终 Bone-RADS 评分计算加权 kappa 和 ICC;Reader 1-3 对「内皮质扇贝样改变」一致度为中等(K=0.59),Reader 2-3 为 K=0.55。

临床应用与阅片要点

  • 对 Bone-RADS-2 软骨性病变,作者认为可考虑追加影像检查而非 X 线随访;使用 Bone-RADS≥3 为阈值时需注意敏感度和 NPV 欠佳。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess the diagnostic performance and the reproducibility of the American College of Radiology (ACR) Bone-RADS score for the radiographic evaluation of bone lesions.

MATERIALS AND METHODS: Patients with histologically proven bone lesion of the extremities and radiographs performed within three months prior to biopsy/surgery were retrospectively enrolled. All radiographs were evaluated using ACR Bone-RADS scoring system by two musculoskeletal radiologists (Readers 1 and 2, with 10 and 3 years of experience in bone tumors imaging, respectively), and one junior general radiologist (Reader 3). Percent agreement, Cohen's Kappa and Conger's Kappa were calculated for all score categories. Weighted-kappa and intraclass correlation coefficient (ICC) were computed for the final Bone-RADS score. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated based on the expert radiologist's diagnosis, using histology as the reference standard.

RESULTS: Final cohort consisted of 285 patients. Substantial to almost perfect agreement was found on almost all Bone-RADS categories. Moderate agreement was found for "endosteal scalloping" between Readers 1-3 (K = 0.59) and Readers 2-3 (K = 0.55). The score showed good diagnostic performance in discriminating between benign and potentially aggressive lesions (AUC = 0.82). Suboptimal sensitivity and NPV were found using a Bone-RADS ≥ 3 cut-off; if enchondroma and atypical cartilaginous tumors were excluded, diagnostic performance significantly improved (AUC = 0.92).

CONCLUSION: The ACR Bone-RADS score showed high reproducibility and good accuracy in identifying benign lesions. In cases of cartilaginous tumors, the score may underestimate the disease, suggesting that additional imaging, rather than radiographic follow-up, could be considered for Bone-RADS-2 chondroid lesions.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Fusco S, Gitto S, Palizzolo E, et al. Diagnostic performance and reproducibility of ACR Bone-RADS for the radiographic evaluation of potentially neoplastic bone lesions. Eur J Radiol. 2025. PMID: 40286551. doi:10.1016/j.ejrad.2025.112128

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。